DURATION-8

GLP-1 Receptor Agonists and SGLT-2 Inhibitors: A Dynamic Duo?

September 23, 2016 First clinical trial to study GLP-1 receptor

Filter by Category

Select some options

Acute Coronary Syndromes (ACS)

Announcements

Article

Artificial intelligence

CAD

Cancer

Cardiometabolic Chronicle

Cardiovascular Disease (CVD)

Cholesterol

CMHC

COVID-19

CVD Prevention

Dementia

Diabetes

Digital Health

Diversity & Inclusion

Diversity and Inclusion

DURATION-8

EMPA REG

Exercise

Faculty Spotlight

Familial Hypercholesterolemia

fitness

Genetics

GLP-1

Heart Failure

Hypercholesterolemia and Statin Intolerance

Hyperkalemia

Hypertension

Hypoglycemia

Inflammation

Infographic

Interventional Cardiology

Keynotes

Lifestyle

Liver

MASH

Medical Technology

Mental Health

Nightly News

Nutrition

Obesity

PAD

PCSK9

Pediatrics

Pharmaceuticals

Pregnancy

Press Releases

Sleep Disorders

Spotlight

Stable Ischemic Heart Disease (SIHD)

Stroke Prevention

Telemedicine

Triglycerides

Type 1 Diabetes

Type 2 Diabetes

Uncategorized

Industry Resources

QUICK LINKS

Professional Education

Industry Resources

Subscribe

Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.

First Name

Last Name

Company / Practice Name

Area of Focus / Specialty

Email

Phone

DURATION-8

GLP-1 Receptor Agonists and SGLT-2 Inhibitors: A Dynamic Duo?

Filter by Category

Industry Resources

See All Publications

Explore On Demand Content

QUICK LINKS

Professional Education

Industry Resources

Subscribe